This practical, user-friendly, and informative text surveys basic principles of toxicology. It is an invaluable guide to evaluating toxicity and related data, approaching toxicity testing and interpretation, and understanding the concepts of hazard prediction and risk assessment and management.

Few scientists have access to the multidisciplinary experience needed for successful assay development and high-throughput screening (HTS) in drug discovery. Designed to give researchers a boost, this text integrates the experience of diverse experts who offer fundamental practical guidance across numerous situations. It introduces emerging technology that allows scientists to identify and capture relevant information. It instructs in how to initiate, validate, optimize, and manage a bioassay intended to screen large collections of compounds. It also identifies critical targets of relevance in drug discovery and treats each individually in terms of the parameters needed for successful assay development.

Examining how to maintain assured quality in clinical trial research, A Practical Guide to Quality Management in Clinical Trial Research provides solid foundations, tips, and techniques for establishing a quality system that will comply with the relevant regulations. This book offers useful information for various standards including Good Laboratory Practice, Good Clinical Practice, and Good Manufacturing Practice. It gives detailed explanations of how to prepare, update, and maintain Standard Operating Procedures and also includes advice on training and development of personnel. This text is ideal for clinical trial monitors and quality assurance personnel in the pharmaceutical industry.

Focusing on the three most critical components that successfully bring an API to market-process development, manufacturing, and governmental regulation and approval-this reference serves as a step-by-step guide to the planning and clear understanding of the bulk manufacturing of APIs. It offers current and timely discussions of the process development cycle, design engineering, the approval process, quality control and assurance, and validation, as well as plant manufacturing activities including materials management, maintenance, and safety. Filling a gap in the literature, this guide covers all the essential information required to effectively plan and execute manufacturing APIs.

One of the first books on the topic, Adaptive Design Methods Clinical Trials presents the principles and methodologies in adaptive design and analysis that pertain to adaptations made to trial or statistical procedures based on accrued data of ongoing clinical trials. The book also offers a well-balanced summary of current regulatory perspectives, recently developed statistical methods, and practical guidelines for choosing an optimal design. Providing a broad range of adaptive design methods that use both analytical and simulation approaches, this resource fills the need for a unified, comprehensive, and updated book in the clinical research and development of adaptive design and analysis.

This book provides a concise, unified presentation of adaptive design theories, uses SAS and R for the design and simulation of adaptive trials, and illustrates how to master different adaptive designs through real-world examples. It emphasizes the relationships among different methods; presents current regulatory views; discusses the challenges in planning, executing, analyzing, and reporting adaptive designs; and features Bayesian decision theory to optimize adaptive designs and programs. The author also explores controversial issues surrounding statistical theories as well as fruitful avenues for future research and applications of adaptive designs.

An overview of how adenosine and inosine regulate immune responses, Adenosine Receptors: Therapeutic Aspects for Inflammatory and Immune Diseases covers aspects of molecular biology, cell biology, and pharmacology. It addresses the role of adenosine receptors in regulating the function of various cell types involved in immune responses. It features data derived from studies using cutting-edge techniques. It discusses disease states such as autoimmune diseases, asthma, atherosclerosis, ischemia-reperfusion injury, and cancer. With contributions from international experts, the text is ideal for researchers in pharmaceutical companies, academic scientists, and clinicians.

Despite being regarded as the most common toxicological target in the endocrine system, the adrenal gland has often been neglected in regulatory testing. Adrenal Toxicology addresses the increased interest in adrenocortical toxicology and the need for a resource that makes techniques available to examine adrenal endocrine disruption.

Examining current techniques and the latest advancements, Adrenal Toxicology reviews the endocrinology, pharmacology, pathology and toxicology of the adrenal gland. This text provides information on the range of drugs and chemicals that affect adrenocortical function and suggests standardized approaches for in vivo and in vitro assessment. This volume also presents recent developments in the molecular mechanisms of toxicity to the adrenal cortex and medulla, and considers environmental adrenal endocrine disruption in sentinel species.

This title demonstrates how advanced formulation designs and delivery technologies can be used to improve drug efficacy and treatment outcomes in particular therapeutic categories or disease states. It discusses nanoparticle systems for cancer treatments, and also presents cutting edge immono-regulation agents for transplantation and the local targeting of drugs, especially poorly water soluble drugs to provide enhanced therapeutic outcomes. In addition, this title highlights areas of therapy showing the most promise for improvement in clinical outcomes via advanced formulation design.

With contributions from international opinion leaders, this title addresses numerous advanced formulation and delivery technologies, including mucoadhesion, chronopharmaceutical delivery through smart delivery devices, targeted nanoparticle systems, and advanced solubilization technologies with liposomal delivery…covers major therapeutic categories such as infectious disease, cancer, CNS disorders, and endocrine disorders…includes pre-clinical or clinical evidence showing an enhanced therapy achieved with advanced formulation design…discusses difficult-to-treat tumors requiring chemotherapeutic agents to pass the blood brain barrier, which is of particular interest for improving the overall efficacy of such drugs with severe side-effects when administered in high doses